bromocriptine has been researched along with pilocarpine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Inano, S; Kaneyuki, H; Mizuki, Y; Ukita, T; Ushijima, I; Yamada, M | 1 |
| Jamshidzadeh, A; Zarrindast, MR | 1 |
| Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M | 1 |
| Mizuki, Y; Ushijima, I; Yamada, M | 1 |
| Hopkins, GA | 1 |
| Baldessarini, RJ; Majocha, R | 1 |
| Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Khan, A; Maqbool, A; Nigar, S; Pottoo, FH; Rasheed, R; Tabassum, N | 1 |
2 review(s) available for bromocriptine and pilocarpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug treatment of glaucoma.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Bromocriptine; Clonidine; Dronabinol; Epinephrine; Glaucoma; Humans; Labetalol; Miotics; Nadolol; Parasympathomimetics; Pilocarpine; Propanolamines; Sympathomimetics; Timolol | 1984 |
8 other study(ies) available for bromocriptine and pilocarpine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
Topics: Animals; Behavior, Animal; Bromocriptine; Dilazep; Dopamine; Dopamine Agents; Injections, Intraperitoneal; Male; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Purines; Rats; Rats, Wistar; Yawning | 1992 |
Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
Topics: Animals; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Physostigmine; Pilocarpine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Yawning | 1992 |
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1988 |
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning | 1988 |
Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dopamine; Drug Tolerance; Male; Motor Activity; Parasympatholytics; Parasympathomimetics; Pilocarpine; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine | 1984 |
The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Fluoxetine; Hippocampus; Male; Mice; Neurons; Oxidative Stress; Pilocarpine; Raloxifene Hydrochloride; Status Epilepticus | 2019 |